Eli Lilly and Company

Healthcare · Drug Manufacturers - General

1,184.60$ +0.0% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Balance Sheet

Eli Lilly and Company (LLY) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 112,476 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet LLY
Line item	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Total Assets	14,307	12,577	12,596	12,825	14,691	16,434	19,042	21,678	24,867	24,581	21,955	26,788	29,213	27,461	31,001	33,660	34,399	35,249	36,308	35,569	38,806	44,981	43,908	39,286	46,633	48,806	49,490	64,006	78,715	112,476
Current Assets	3,891	5,321	5,407	7,056	7,943	6,939	7,804	8,759	12,836	10,796	9,694	12,316	12,453	12,487	14,840	14,248	13,039	13,105	11,928	12,574	15,101	19,202	20,550	13,710	17,462	18,452	18,035	25,727	32,740	55,629
Cash	814	1,948	1,496	3,700	4,115	2,702	1,946	2,756	5,365	3,007	3,109	3,221	5,497	4,463	5,993	5,923	4,019	3,830	3,872	3,666	4,582	6,536	7,321	2,338	3,657	3,819	2,067	2,819	3,268	7,163
Cash & Short-Term Investments	814	1,948	1,496	3,836	4,618	3,731	3,655	3,713	7,464	5,038	3,891	4,831	5,926	4,498	6,727	6,897	5,684	5,397	4,827	4,452	6,039	8,034	7,409	2,439	3,681	3,909	2,212	2,928	3,423	7,268
Receivables	1,737	1,883	2,244	1,843	1,966	1,695	2,074	2,343	2,553	2,762	2,694	3,705	3,277	3,832	4,158	4,238	3,888	4,023	3,801	4,072	4,766	5,262	5,777	5,542	6,929	8,127	8,559	11,336	13,275	20,155
Inventory	881	901	1,000	900	883	1,060	1,495	1,963	2,292	1,878	2,270	2,524	2,493	2,850	2,518	2,300	2,644	2,929	2,740	3,446	3,562	4,458	3,098	3,191	3,980	3,886	4,310	5,773	7,589	13,744
Property, Plant & Equipment	–	–	–	–	4,177	4,532	5,293	6,539	7,551	7,913	8,152	8,575	8,626	8,197	7,941	7,760	7,760	7,976	7,964	8,054	8,253	8,827	8,920	7,873	8,682	8,985	10,144	12,914	17,102	25,935
Goodwill	–	–	–	–	–	–	–	–	–	–	–	746	1,168	1,175	1,424	1,435	1,501	1,517	1,758	4,040	3,973	4,370	1,367	3,679	3,767	3,892	4,073	4,940	5,770	5,898
Intangible Assets	4,028	1,551	1,518	119	115	93	95	92	110	140	130	1,710	2,887	2,525	3,395	3,693	3,251	2,814	2,884	5,035	4,358	4,029	1,068	6,618	7,450	7,692	7,207	6,907	6,166	6,521
Total Liabilities	8,207	7,772	8,166	7,812	8,644	9,330	10,768	11,913	13,947	13,789	10,975	13,371	22,477	17,936	18,589	20,124	19,625	17,608	20,920	20,979	24,725	33,313	32,999	36,587	40,808	39,651	38,714	53,143	64,443	85,941
Current Liabilities	4,222	4,192	4,607	3,935	4,961	5,203	5,064	5,551	7,594	5,716	5,086	5,268	13,110	6,568	7,101	8,931	8,390	8,917	11,208	8,230	10,987	14,536	11,888	11,775	12,482	15,053	17,138	27,293	28,377	35,228
Short-Term Debt	1,213	228	181	242	184	286	545	197	2,021	735	219	414	5,846	27	156	1,522	12	1,013	2,689	6.1	1,937	3,707	1,102	1,499	8.7	1,538	1,501	6,905	5,117	1,635
Accounts Payable	829	986	1,186	446	662	624	677	876	649	781	789	924	886	968	1,072	1,125	1,188	1,119	1,128	1,338	1,349	1,411	1,207	1,405	1,607	1,671	1,931	2,599	3,229	5,379
Long-Term Debt	–	–	–	–	2,634	3,132	4,358	4,688	4,492	5,764	3,494	4,594	4,616	6,635	6,771	5,465	5,519	4,200	5,368	7,972	8,368	9,941	11,640	13,818	16,587	15,346	14,738	18,321	28,527	40,868
Shareholders' Equity	6,100	4,646	4,430	5,013	6,047	7,104	8,274	9,765	10,920	10,792	10,981	13,504	6,735	9,524	12,420	13,542	14,765	17,631	15,373	14,571	14,008	11,592	10,909	2,607	5,642	8,979	10,650	10,772	14,192	26,535
Retained Earnings	7,207	4,483	4,229	4,986	6,223	7,411	8,500	9,470	9,725	10,027	10,927	11,807	7,655	9,830	12,733	14,898	16,088	16,992	16,483	16,012	16,046	13,894	11,396	4,920	7,830	8,959	10,043	10,312	13,545	24,470
Shares Outstanding	1,117	1,131	1,120	1,106	1,096	1,090	1,083	1,081	1,090	1,094	1,087	1,091	1,094	1,098	1,106	1,114	1,146	1,117	1,111	1,105	1,101	1,052	1,034	958	957	954	950	903	904	898

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings